Tapewire

Nasdaq · USD

BTCS

BTCS Inc.

Export transactions ↓
Tapewire entity
7074
SEC CIK
0001436229
Parsed reports
132

Last 12 months

Inside the activity.

3 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202530
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202606
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 22, 2022 Filed Feb 23, 2022 21:01 UTC GrantCommon Stock 40,046 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-005230 · ownership.xml · nonDerivative · entry 2

Paranjape Manish · CIK 0001912833 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,813

F2 · security: Represents long-term incentive restricted stock units. Each long-term incentive restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The long-term incentive restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $100,000,000. Once the market capitalization target has been met, 20% of the restricted stock units will vest on the one-year anniversary of the Transaction Date, and the remaining 80% of the restricted stock units will vest monthly over the four years following the one year anniversary of the Transaction Date.

F6 · security: The vesting and delivery of the shares of common stock underlying the reported securities are subject to the receipt of shareholder approval approving an increase in the authorized shares under the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 21:01 UTC GrantCommon Stock 45,767 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-005230 · ownership.xml · nonDerivative · entry 1

Paranjape Manish · CIK 0001912833 · CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,767

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest as follows: (i) one-fifth on February 22, 2023 and (ii) the remaining in 48 equal (monthly) increments, with each vesting tranche being subject to continued employment on such applicable vesting date.

F6 · security: The vesting and delivery of the shares of common stock underlying the reported securities are subject to the receipt of shareholder approval approving an increase in the authorized shares under the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 4, 2022 21:08 UTC GrantCommon Stock 55,556 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000363 · ownership.xml · nonDerivative · entry 4

Prevoznik Michael Edward JR · CIK 0001898290 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,224

F4 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $400,000,000. Once the market capitalization target has been met, 20% of the restricted stock units will vest on the one-year anniversary of the Grant Date, and the remaining 80% of the restricted stock units will vest monthly over the four years following the one year anniversary of the Grant Date.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 4, 2022 21:08 UTC GrantCommon Stock 55,556 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000363 · ownership.xml · nonDerivative · entry 3

Prevoznik Michael Edward JR · CIK 0001898290 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,668

F3 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $200,000,000. Once the market capitalization target has been met, 20% of the restricted stock units will vest on the one-year anniversary of the Grant Date, and the remaining 80% of the restricted stock units will vest monthly over the four years following the one year anniversary of the Grant Date.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 4, 2022 21:08 UTC GrantCommon Stock 55,556 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000363 · ownership.xml · nonDerivative · entry 2

Prevoznik Michael Edward JR · CIK 0001898290 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,112

F2 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $150,000,000. Once the market capitalization target has been met, 20% of the restricted stock units will vest on the one-year anniversary of the Grant Date, and the remaining 80% of the restricted stock units will vest monthly over the four years following the one year anniversary of the Grant Date.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 4, 2022 21:08 UTC GrantCommon Stock 55,556 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000363 · ownership.xml · nonDerivative · entry 1

Prevoznik Michael Edward JR · CIK 0001898290 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,556

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $100,000,000. Once the market capitalization target has been met, 20% of the restricted stock units will vest on the one-year anniversary from January 2, 2022 (the "Grant Date"), and the remaining 80% of the restricted stock units will vest monthly over the four years following the one year anniversary of the Grant Date.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:09 UTC GrantCommon Stock 31,848 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000369 · ownership.xml · nonDerivative · entry 1

Garrity David · CIK 0001720019 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,638

F1 · shares: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest in four equal installments at the end of each calendar quarter.

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:14 UTC
Handerhan MichalDirector · COO · 10% owner
GrantCommon Stock 111,111 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000379 · ownership.xml · nonDerivative · entry 5

Handerhan Michal · CIK 0001599522 · Director · COO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,608,497

F4 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $400,000,000.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:14 UTC
Handerhan MichalDirector · COO · 10% owner
GrantCommon Stock 111,111 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000379 · ownership.xml · nonDerivative · entry 4

Handerhan Michal · CIK 0001599522 · Director · COO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,497,386

F3 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $200,000,000.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:14 UTC
Handerhan MichalDirector · COO · 10% owner
GrantCommon Stock 111,111 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000379 · ownership.xml · nonDerivative · entry 3

Handerhan Michal · CIK 0001599522 · Director · COO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,386,275

F2 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $150,000,000.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:14 UTC
Handerhan MichalDirector · COO · 10% owner
GrantCommon Stock 111,111 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000379 · ownership.xml · nonDerivative · entry 2

Handerhan Michal · CIK 0001599522 · Director · COO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,275,164

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $100,000,000.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:14 UTC
Handerhan MichalDirector · COO · 10% owner
GrantCommon Stock 111,111 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000379 · ownership.xml · nonDerivative · entry 1

Handerhan Michal · CIK 0001599522 · Director · COO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,164,053

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:12 UTC
Allen Charles WDirector · CEO · 10% owner
GrantCommon Stock 173,611 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000374 · ownership.xml · nonDerivative · entry 5

Allen Charles W · CIK 0001599502 · Director · CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,022,874

F4 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $400,000,000.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:12 UTC
Allen Charles WDirector · CEO · 10% owner
GrantCommon Stock 173,611 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000374 · ownership.xml · nonDerivative · entry 4

Allen Charles W · CIK 0001599502 · Director · CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,849,263

F3 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $200,000,000.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:12 UTC
Allen Charles WDirector · CEO · 10% owner
GrantCommon Stock 173,611 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000374 · ownership.xml · nonDerivative · entry 3

Allen Charles W · CIK 0001599502 · Director · CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,675,652

F2 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $150,000,000.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:12 UTC
Allen Charles WDirector · CEO · 10% owner
GrantCommon Stock 173,611 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000374 · ownership.xml · nonDerivative · entry 2

Allen Charles W · CIK 0001599502 · Director · CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,502,041

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $100,000,000.

F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules.

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:12 UTC
Allen Charles WDirector · CEO · 10% owner
GrantCommon Stock 173,611 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000374 · ownership.xml · nonDerivative · entry 1

Allen Charles W · CIK 0001599502 · Director · CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,328,430

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:10 UTC GrantCommon Stock 31,848 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000372 · ownership.xml · nonDerivative · entry 1

Lee Charles Benjamin · CIK 0001751744 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,348

F1 · shares: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest in four equal installments at the end of each calendar quarter.

Read SEC document
January 02, 2022 Filed Jan 5, 2022 02:10 UTC GrantCommon Stock 31,848 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-000371 · ownership.xml · nonDerivative · entry 1

Van Cleef Carol R · CIK 0001856584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,444

F1 · shares: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest in four equal installments at the end of each calendar quarter.

Read SEC document
September 14, 2021 Filed Sep 14, 2021 20:05 UTC ConversionSeries C-2 Convertible Preferred Stock · Derivative 15,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-21-022685 · ownership.xml · derivative · entry 2

Garrity David · CIK 0001720019 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 54,706 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F3 · price: Not applicable.

F1 · derivative.exercise_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F1 · derivative.expiration_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F2 · derivative.underlying_shares: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4.

Read SEC document
September 14, 2021 Filed Sep 14, 2021 20:05 UTC ConversionCommon Stock 54,706 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-21-022685 · ownership.xml · nonDerivative · entry 1

Garrity David · CIK 0001720019 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F1 · price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F2 · balance_after: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4.

Read SEC document
September 14, 2021 Filed Sep 14, 2021 20:05 UTC
Handerhan MichalDirector · Chief Operating Officer · 10% owner
ConversionSeries C-2 Convertible Preferred Stock · Derivative 275,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-21-022684 · ownership.xml · derivative · entry 2

Handerhan Michal · CIK 0001599522 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,002,942 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F3 · price: Not applicable.

F1 · derivative.exercise_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F1 · derivative.expiration_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F2 · derivative.underlying_shares: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4.

Read SEC document
September 14, 2021 Filed Sep 14, 2021 20:05 UTC
Handerhan MichalDirector · Chief Operating Officer · 10% owner
ConversionCommon Stock 1,002,942 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-21-022684 · ownership.xml · nonDerivative · entry 1

Handerhan Michal · CIK 0001599522 · Director · Chief Operating Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,052,942

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F1 · price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F2 · balance_after: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4.

Read SEC document
September 14, 2021 Filed Sep 14, 2021 20:05 UTC
Allen Charles WDirector · Chief Executive Officer · 10% owner
ConversionSeries C-2 Convertible Preferred Stock · Derivative 810,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-21-022683 · ownership.xml · derivative · entry 2

Allen Charles W · CIK 0001599502 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,954,118 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F3 · price: Not applicable.

F1 · derivative.exercise_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F1 · derivative.expiration_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F2 · derivative.underlying_shares: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4.

Read SEC document
September 14, 2021 Filed Sep 14, 2021 20:05 UTC
Allen Charles WDirector · Chief Executive Officer · 10% owner
ConversionCommon Stock 2,954,118 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-21-022683 · ownership.xml · nonDerivative · entry 1

Allen Charles W · CIK 0001599502 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,154,819

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F1 · price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F2 · balance_after: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4.

Read SEC document
June 28, 2021 Filed Jun 30, 2021 16:03 UTC
Lee AndrewChief Financial Officer
GrantCommon Stock 507,813 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-015713 · ownership.xml · nonDerivative · entry 1

Lee Andrew · CIK 0001870177 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 507,813

F1 · security: Represents restricted stock units ("RSUs"). Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest over a five-year period as follows: (i) 20% of the RSUs (101,563) will vest on the one-year anniversary of the Transaction Date and (ii) the remaining 80% of the RSUs (406,250) will vest monthly over the following four years, with each applicable incremental vesting amount being subject to the reporting person's continued service as the Chief Financial Officer of the issuer.

Read SEC document
April 22, 2021 Filed Apr 23, 2021 16:22 UTC
Allen Charles WDirector · CEO, CFO
PurchaseCommon Stock 7,009 $5,700.00 $39,951,300.00
Disclosure

SEC source: 0001493152-21-009521 · ownership.xml · nonDerivative · entry 1

Allen Charles W · CIK 0001599502 · Director · CEO, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,007,009

F1 · security: The Reporting Person purchased the shares in a private transaction - not on the open market. Two million of the reported shares represented unvested restricted stock units.

Read SEC document
April 01, 2021 Filed Apr 12, 2021 20:05 UTC GrantStock Options (Right to Buy) · Derivative 175,000 Not disclosed Strike: $1.03 Not disclosed
Disclosure

SEC source: 0001493152-21-008539 · ownership.xml · derivative · entry 2

Lee Charles Benjamin · CIK 0001751744 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2026-04-01

F2 · security: The stock options shall vest as follow: 70,000 options will vest on April 1, 2022 and the remaining options will vest based upon the following milestones involving the issuer's stock price: 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $1.288; 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $1.609; 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $2.012; and 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $2.515.

F3 · price: Not applicable.

Read SEC document
April 01, 2021 Filed Apr 12, 2021 20:05 UTC GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-008539 · ownership.xml · nonDerivative · entry 1

Lee Charles Benjamin · CIK 0001751744 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the issuer lists its Common Stock on a national securities exchange.

Read SEC document
April 01, 2021 Filed Apr 13, 2021 20:05 UTC GrantStock Options (Right to Buy) · Derivative 175,000 Not disclosed Strike: $1.03 Not disclosed
Disclosure

SEC source: 0001493152-21-008648 · ownership.xml · derivative · entry 2

Van Cleef Carol R · CIK 0001856584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2026-04-01

F2 · security: The stock options shall vest as follow: 70,000 options will vest on April 1, 2022 and the remaining options will vest based upon the following milestones involving the issuer's stock price: 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $1.288; 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $1.609; 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $2.012; and 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $2.515.

F3 · price: Not applicable.

Read SEC document
April 01, 2021 Filed Apr 13, 2021 20:05 UTC GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-008648 · ownership.xml · nonDerivative · entry 1

Van Cleef Carol R · CIK 0001856584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,958

F1 · shares: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the issuer lists its Common Stock on a national securities exchange.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:36 UTC
Allen Charles WDirector · CEO, CFO
GrantStock Options (Right to Buy) · Derivative 7,500,000 Not disclosed Strike: $0.19 Not disclosed
Disclosure

SEC source: 0001493152-21-000223 · ownership.xml · derivative · entry 3

Allen Charles W · CIK 0001599502 · Director · CEO, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500,000

Underlying: Common Stock · 7,500,000 shares

Expires not disclosed

F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received.

F5 · security: Not applicable.

F5 · price: Not applicable.

F4 · derivative.exercise_date: The stock options shall vest as follow: 3 million options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price.

F4 · derivative.expiration_date: The stock options shall vest as follow: 3 million options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:36 UTC
Allen Charles WDirector · CEO, CFO
GrantSeries C-2 Convertible Preferred Stock · Derivative 810,000 $810,000.00 Strike: $0.17 $656,100,000,000.00
Disclosure

SEC source: 0001493152-21-000223 · ownership.xml · derivative · entry 2

Allen Charles W · CIK 0001599502 · Director · CEO, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,764,706

Underlying: Common Stock · 4,764,706 shares

Expires not disclosed

F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received.

F3 · derivative.exercise_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F3 · derivative.expiration_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:36 UTC
Allen Charles WDirector · CEO, CFO
GrantCommon Stock 2,000,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-000223 · ownership.xml · nonDerivative · entry 1

Allen Charles W · CIK 0001599502 · Director · CEO, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000,000

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the issuer lists its Common Stock on the Nasdaq or NYSE.

F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:31 UTC
Handerhan MichalDirector · COO
GrantStock Options (Right to Buy) · Derivative 3,500,000 Not disclosed Strike: $0.19 Not disclosed
Disclosure

SEC source: 0001493152-21-000216 · ownership.xml · derivative · entry 3

Handerhan Michal · CIK 0001599522 · Director · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500,000

Underlying: Common Stock · 3,500,000 shares

Expires not disclosed

F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received.

F5 · security: Not applicable.

F5 · price: Not applicable.

F4 · derivative.exercise_date: The stock options shall vest as follow: 1.4 million options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price.

F4 · derivative.expiration_date: The stock options shall vest as follow: 1.4 million options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:31 UTC
Handerhan MichalDirector · COO
GrantSeries C-2 Convertible Preferred Stock · Derivative 275,000 $810,000.00 Strike: $0.17 $222,750,000,000.00
Disclosure

SEC source: 0001493152-21-000216 · ownership.xml · derivative · entry 2

Handerhan Michal · CIK 0001599522 · Director · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,617,647

Underlying: Common Stock · 1,617,647 shares

Expires not disclosed

F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received.

F3 · derivative.exercise_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F3 · derivative.expiration_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:31 UTC
Handerhan MichalDirector · COO
GrantCommon Stock 500,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-000216 · ownership.xml · nonDerivative · entry 1

Handerhan Michal · CIK 0001599522 · Director · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the issuer lists its Common Stock on the Nasdaq or NYSE.

F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:33 UTC GrantStock Options (Right to Buy) · Derivative 1,000,000 Not disclosed Strike: $0.19 Not disclosed
Disclosure

SEC source: 0001493152-21-000220 · ownership.xml · derivative · entry 3

Garrity David · CIK 0001720019 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires not disclosed

F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received.

F5 · security: Not applicable.

F5 · price: Not applicable.

F4 · derivative.exercise_date: The stock options shall vest as follow: 400 thousand options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price.

F4 · derivative.expiration_date: The stock options shall vest as follow: 400 thousand options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:33 UTC GrantSeries C-2 Convertible Preferred Stock · Derivative 15,000 $15,000.00 Strike: $0.17 $225,000,000.00
Disclosure

SEC source: 0001493152-21-000220 · ownership.xml · derivative · entry 2

Garrity David · CIK 0001720019 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,235

Underlying: Common Stock · 88,235 shares

Expires not disclosed

F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received.

F3 · derivative.exercise_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F3 · derivative.expiration_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 21:33 UTC GrantCommon Stock 250,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-000220 · ownership.xml · nonDerivative · entry 1

Garrity David · CIK 0001720019 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,835

F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the issuer lists its Common Stock on the Nasdaq or NYSE.

F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received.

Read SEC document
January 01, 2021 Filed Jan 20, 2021 19:48 UTC Amendment
Handerhan MichalDirector · COO
GrantSeries C-2 Convertible Preferred Stock · Derivative 275,000 $275,000.00 Strike: $0.17 $75,625,000,000.00
Disclosure

SEC source: 0001493152-21-001419 · ownership.xml · derivative · entry 1

Handerhan Michal · CIK 0001599522 · Director · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,617,647

Underlying: Common Stock · 1,617,647 shares

Expires not disclosed

F1 · security: The Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received.

F3 · price: The price of the securities in the original Form 4 was erroneously disclosed as $810,000. This Form 4/A amends the original to Form 4 to correct this error.

F2 · derivative.exercise_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

F2 · derivative.expiration_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange.

Read SEC document
February 08, 2019 Filed Feb 9, 2019 02:30 UTC
Handerhan MichalDirector · Chief Operating Officer
SaleCommon Stock 2,437,627 $0.01 $29,251.52
Disclosure

SEC source: 0001493152-19-001636 · ownership.xml · nonDerivative · entry 1

Handerhan Michal · CIK 0001599522 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
December 12, 2018 Filed Dec 12, 2018 22:00 UTC
Allen Charles WDirector · CEO, CFO
SaleCommon Stock 1,857,829 $0.02 $37,156.58
Disclosure

SEC source: 0001493152-18-017388 · ownership.xml · nonDerivative · entry 1

Allen Charles W · CIK 0001599502 · Director · CEO, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
July 28, 2017 Filed Jul 28, 2017 17:51 UTC
Handerhan MichalDirector · COO
Exercise / conversionWarrants · Derivative 1,556 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001493152-17-008236 · form4.xml · derivative · entry 6

Handerhan Michal · CIK 0001599522 · Director · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,556 shares

Expires 2020-04-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 28, 2017 Filed Jul 28, 2017 17:51 UTC
Handerhan MichalDirector · COO
Exercise / conversionWarrants · Derivative 2,084 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001493152-17-008236 · form4.xml · derivative · entry 5

Handerhan Michal · CIK 0001599522 · Director · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,084 shares

Expires 2020-01-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 28, 2017 Filed Jul 28, 2017 17:51 UTC
Handerhan MichalDirector · COO
Tax withholdingCommon Stock 663 $0.08 $49.73
Disclosure

SEC source: 0001493152-17-008236 · form4.xml · nonDerivative · entry 4

Handerhan Michal · CIK 0001599522 · Director · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,437,627

Read SEC document
July 28, 2017 Filed Jul 28, 2017 17:51 UTC
Handerhan MichalDirector · COO
Exercise / conversionCommon Stock 1,556 $0.03 $49.79
Disclosure

SEC source: 0001493152-17-008236 · form4.xml · nonDerivative · entry 3

Handerhan Michal · CIK 0001599522 · Director · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,438,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 28, 2017 Filed Jul 28, 2017 17:51 UTC
Handerhan MichalDirector · COO
Tax withholdingCommon Stock 695 $0.08 $52.13
Disclosure

SEC source: 0001493152-17-008236 · form4.xml · nonDerivative · entry 2

Handerhan Michal · CIK 0001599522 · Director · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,436,734

Read SEC document
July 28, 2017 Filed Jul 28, 2017 17:51 UTC
Handerhan MichalDirector · COO
Exercise / conversionCommon Stock 2,084 $0.03 $52.10
Disclosure

SEC source: 0001493152-17-008236 · form4.xml · nonDerivative · entry 1

Handerhan Michal · CIK 0001599522 · Director · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,437,429

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 28, 2017 Filed Jul 28, 2017 17:49 UTC
Allen Charles WDirector · CEO,CFO
Exercise / conversionWarrants · Derivative 1,556 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001493152-17-008235 · form4.xml · derivative · entry 6

Allen Charles W · CIK 0001599502 · Director · CEO,CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,556 shares

Expires 2020-04-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.